Home

predare Definitiv Recunoscător ioannis gounaris cambridge exterior Palatul copiilor ca asta

Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals

400+ "Gounaris" profiles | LinkedIn
400+ "Gounaris" profiles | LinkedIn

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or  Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective,  Single-Institution Study. - Abstract - Europe PMC
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study. - Abstract - Europe PMC

Trabectedin for advanced soft tissue sarcomas: a single institution  experience
Trabectedin for advanced soft tissue sarcomas: a single institution experience

Ioannis Gounaris's research works | Novartis, Basel and other places
Ioannis Gounaris's research works | Novartis, Basel and other places

Ioannis Gounaris - Executive Medical Director - Merck Group | LinkedIn
Ioannis Gounaris - Executive Medical Director - Merck Group | LinkedIn

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as  Biomarkers of Treatment Response for Patients with Relapsed High-Grade  Serous Ovarian Carcinoma: A Retrospective Study | PLOS Medicine
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study | PLOS Medicine

7 perfiles de «Ioannis Gounaris» | LinkedIn
7 perfiles de «Ioannis Gounaris» | LinkedIn

Cambridge City Council on Twitter: "Cambridge market will reopen on Monday  (18 January) with traders selling fresh food and produce, plants and cycle  services. Full details: https://t.co/A7FZJIn6ki #StaySafeCambridge  https://t.co/oeDAb869qx" / Twitter
Cambridge City Council on Twitter: "Cambridge market will reopen on Monday (18 January) with traders selling fresh food and produce, plants and cycle services. Full details: https://t.co/A7FZJIn6ki #StaySafeCambridge https://t.co/oeDAb869qx" / Twitter

Ioannis Gounaris - Executive Medical Director - Merck Group | LinkedIn
Ioannis Gounaris - Executive Medical Director - Merck Group | LinkedIn

7 “Ioannis Gounaris” profil | LinkedIn
7 “Ioannis Gounaris” profil | LinkedIn

Ioannis Gounaris's research works | Novartis, Basel and other places
Ioannis Gounaris's research works | Novartis, Basel and other places

Ioannis Gounaris's research works | Novartis, Basel and other places
Ioannis Gounaris's research works | Novartis, Basel and other places

CRUK Cambridge Institute ar Twitter: "A huge congratulations to Dr Oscar  Rueda on his new position at the @MRC_BSU @Cambridge_Uni! Oscar has been in  our @CaldasLab working on the Personalised Breast Cancer
CRUK Cambridge Institute ar Twitter: "A huge congratulations to Dr Oscar Rueda on his new position at the @MRC_BSU @Cambridge_Uni! Oscar has been in our @CaldasLab working on the Personalised Breast Cancer

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in  neoadjuvant sequential epirubicin, cyclophosphamide,
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide,

Ioannis Gounaris's research works | Novartis, Basel and other places
Ioannis Gounaris's research works | Novartis, Basel and other places

Application of ARID1A to murine formalin-fixed... | F1000Research
Application of ARID1A to murine formalin-fixed... | F1000Research

Ioannis Gounaris's research works | Novartis, Basel and other places
Ioannis Gounaris's research works | Novartis, Basel and other places

Trabectedin for advanced soft tissue sarcomas: a single institution  experience | Future Oncology
Trabectedin for advanced soft tissue sarcomas: a single institution experience | Future Oncology

Docetaxel and its potential in the treatment of refractory esophagogastric  adenocarcinoma
Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma

Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals

Trabectedin for advanced soft tissue sarcomas: a single institution  experience | Future Oncology
Trabectedin for advanced soft tissue sarcomas: a single institution experience | Future Oncology

7 perfiles de «Ioannis Gounaris» | LinkedIn
7 perfiles de «Ioannis Gounaris» | LinkedIn

Our Publications
Our Publications

Ovarian clear cell carcinoma—bad endometriosis or bad endometrium? -  Gounaris - 2011 - The Journal of Pathology - Wiley Online Library
Ovarian clear cell carcinoma—bad endometriosis or bad endometrium? - Gounaris - 2011 - The Journal of Pathology - Wiley Online Library

Natasha LeGresley (@tashlegr) / Twitter
Natasha LeGresley (@tashlegr) / Twitter